Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Iron Deficiency Anemia During Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Singleton pregnancy.~2. Gestational age 14-18 weeks.~3. Mild to moderate anemia~4. No associated medical or obstetric complications.~5. Women not already receiving iron therapy.~6. Women accepted to participate in the study.~Exclusion Criteria:~1. Multiple pregnancy~2. Severe anemia~3. Iron hypersensitivity.~4. Liver diseases.~5. Women refuse to participate in the study.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Ferrous bis-glycinate group (Type: ACTIVE_COMPARATOR): The patients will receive oral ferrous bis-glycinate fully reacted amino acid 27 mg tablets (Pharaferro 27 tablets) once daily for eight consecutive weeks.
- Ferrous glycine sulphate group (Type: ACTIVE_COMPARATOR): The patients will receive 567.6 mg of ferrous glycine sulphate capsules (Ferrosanol duodenale capsules, Schwarz) once daily for eight consecutive weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).